Personal Data Protection Policy

In accordance with General Data Protection Regulation (GDPR), you are hereby informed that your data will be used for the purpose of personnel recruitment.

The user should ensure that the personal data provided are truthful and is responsible for communicating any changes to PharmaMar. These data will be kept for 5 years unless you ask us to delete them in advance.

Users may exercise their rights to request access, portability, rectification, deletion, limitation or opposition to the processing of their data, by contacting PharmaMar´s Data Protection Officer at the following address dpo@pharmamar.com.

Your CV may be transferred to other companies of the PharmaMar group in order to include your application in the selection processes they may carry out. If you do not agree with this transfer, please inform us at the e-mail address indicated above.

Prior to sending the form, the user will accept this privacy policy by selecting the appropriate box, thereby giving consent to the processing of their data under the conditions indicated and this being the legal basis for processing.

Likewise, the user who considers that his/her rights have been compromised may contact the Data Protection Officer in the same way, prior to filing a complaint with the Spanish Data Protection Agency.

Science & Innovation

Our strong commitment to oncology translational research along with our deep understanding of the marine biodiversity of our oceans is placing us at the head of marine biotechnology.

Oncology pipeline

PharmaMar develops and commercializes YONDELIS® in Europe and has three clinical-stage drug candidates under development for several types of solid and hematological cancers, Aplidin ®, Lurbinectedin, and PM184.

Newsroom

If you need information about the company, our clinical trials, corporate images or multimedia, visit our newsroom